PEAK Stock Recent News

HealthPeak Properties and Physicians Realty Trust have agreed to combine in an all-stock merger of equals valued at about $21 billion, the companies said on Monday.

Healthpeak Properties is an undervalued healthcare REIT with a well-covered yield and a BBB+ credit rating. The company's portfolio is diverse, including life science properties, outpatient medical care, and continuing care retirement communities. Despite macro worries and market downturns, Healthpeak Properties has strong fundamentals and potential for growth, making it an attractive investment.

Healthpeak (PEAK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Robust demand for Healthpeak's (PEAK) lab assets and a rise in senior citizen's healthcare expenditure are expected to have benefited its Q3 earnings.

DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: PEAK), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, is scheduled to report third quarter 2023 financial results after the close of trading on the New York Stock Exchange on Monday, October 30, 2023. Healthpeak will host a conference call and webcast on Tuesday, October 31, 2023, at 8:00 a.m. Mountain Time (10:00 a.m. Eastern Time) in order to review its financial performance and operati.

Well, you don't have to conjure up some investment that doesn't exist. Real estate investment trusts, often called REITs,  are mandated to distribute profits to shareholders to maintain their special tax status.

With inflation across the United States proving to be more persistent than initially thought and the FED raising the cost of financing in myriad products from new homes to car loans, it is more important than ever for your money to really crank up the sweat factory.

The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies.

Healthpeak Properties, a healthcare REIT, is considered a potentially attractive investment due to its qualitative safety, good upside, and significantly above-average yield. The company's portfolio includes life science properties, outpatient medical care, and continuing care retirement communities, with a strong balance sheet and fundamentals, including a BBB+ rating and low net debt. Despite an unfavorable macro environment, Healthpeak had a strong start to 2023, with a focus on the life science and outpatient segment due to strong demand and fundamentals.

Healthpeak's (PEAK) Q2 earnings outshine estimates on higher revenues. Same-store portfolio cash (adjusted) net operating income improves year over year.